P2RX7 and Abnormal retinal morphology: A recent genetic study has demonstrated that a haplotype containing a rare genetic variant of P2X7 receptor is associated with increased susceptibility to AMD [29].Moreover, Notomi et al. recently proposed Brilliant Blue G (BBG), a selective P2X7 receptor antagonist, as a neuroprotective agent in retinal diseases [30].